Lymphoma and Non-Acute Leukemia with Other Procedures with MCC: Inpatient Reimbursement Overview
DRG 823 applies to inpatient hospitalizations for lymphoma and non-acute leukemia when other significant procedures are performed and a Major Complication or Comorbidity is present. This Diagnosis-Related Group reflects higher resource use and influences Medicare inpatient reimbursement by assigning a higher payment weight for cases with major complications and additional procedures.
Customize your policy alerts
Sign up for drg 823 policy alerts
Get alerted when payer policies referencing 823 are released or updated.
Monitor payer policy activity
DRG 823 Overview
DRG 823 covers inpatient stays for patients with lymphoma and non-acute leukemia who undergo other significant procedures and have a Major Complication or Comorbidity. This category captures higher-resource hospitalizations where additional operative or procedural care substantially affects costs. It is important for Medicare payment because the presence of a Major Complication or Comorbidity and qualifying procedures increase reimbursement relative to less complex groups. Accurate coding of principal diagnosis, procedures, and complications determines assignment to this Diagnosis-Related Group and the associated payment weight.